Water Quality in SOLDOTNA, AK (99669)
EPA violation data for public water systems serving ZIP code 99669.
771
Total Violations
300
Health-Based
471
Monitoring / Reporting
759
Resolved
What does this mean?
759 of 771 violations have been resolved. 300 are health-based violations, meaning contaminant levels exceeded federal safety limits. The remaining 471 are monitoring or reporting violations (missed testing deadlines or late paperwork — not necessarily a water quality issue). Not all violations mean your water is unsafe. The EPA requires reporting even for minor administrative issues.
Water systems: 185 Population served: 20,747
Violations Detail (771 total)
| Contaminant | Category | MCL Limit | Measured | Date | Status | Health Effects |
|---|---|---|---|---|---|---|
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.017 | Jun 30, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.017 | Jun 30, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Chlordane | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Heptachlor | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Glyphosate | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| 2,3,7,8-TCDD | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Diquat | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Cardiovascular system or reproductive problems |
| Endothall | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Cardiovascular system or reproductive problems |
| Heptachlor | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| 2,3,7,8-TCDD | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Endothall | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Diquat | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Glyphosate | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Feb 3, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Endothall | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Diquat | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Glyphosate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 2,3,7,8-TCDD | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | Cardiovascular system or reproductive problems |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | Cardiovascular system or reproductive problems |
| 2,3,7,8-TCDD | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Glyphosate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Diquat | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Endothall | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 2,3,7,8-TCDD | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Glyphosate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Endothall | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Diquat | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | Cardiovascular system or reproductive problems |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jul 1, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 19, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.02 | May 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | May 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | May 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | May 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 27, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.018 | Apr 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Apr 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Apr 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Apr 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.02 | Feb 29, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Feb 29, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Feb 29, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Feb 29, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.025 | Jan 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.025 | Jan 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.025 | Jan 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.025 | Jan 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Health-Based | N/A | 0.024 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.024 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.024 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.024 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Groundwater Rule | Monitoring | N/A | N/A | Dec 20, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.033 | Nov 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.033 | Nov 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.033 | Nov 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.033 | Nov 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.033 | Nov 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.033 | Nov 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.033 | Nov 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.033 | Nov 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.033 | Nov 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.028 | Oct 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.028 | Oct 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.028 | Oct 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.028 | Oct 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.028 | Oct 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.028 | Oct 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.028 | Oct 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.028 | Oct 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 27, 2023 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.016 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.02 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.027 | Aug 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.027 | Aug 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.027 | Aug 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.027 | Aug 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.027 | Aug 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.027 | Aug 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.027 | Aug 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.027 | Aug 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.027 | Aug 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 9, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Groundwater Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.023 | Jul 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | Jul 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | Jul 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | Jul 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | Jul 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | Jul 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | Jul 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | Jul 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | Jul 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.016 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.02 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.02 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 10, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 10, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 10, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.023 | May 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | May 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | May 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | May 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | May 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | May 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | May 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | May 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | May 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | May 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | May 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | May 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | May 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | May 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | May 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.023 | May 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.022 | Apr 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Apr 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Apr 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Apr 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Apr 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Apr 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Apr 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Apr 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Apr 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Apr 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Apr 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Apr 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Apr 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Apr 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Apr 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.022 | Apr 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.017 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.017 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.017 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.017 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.018 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 19, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 9, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.016 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.014 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 11, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 11, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 11, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 9, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 18, 2021 | Resolved | N/A |
Lead & Copper Levels
Violation Timeline
2025(86)
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Active
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Active
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
BHC-GAMMA
03
Mar 31Resolved
Hexachlorocyclopentadiene
03
Mar 31Resolved
Pentachlorophenol
03
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Chlordane
03
Mar 31Resolved
Endrin
03
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Heptachlor
03
Mar 31Resolved
Dinoseb
03
Mar 31Resolved
ETHYLENE DIBROMIDE
03
Mar 31Resolved
Methoxychlor
03
Mar 31Resolved
Toxaphene
03
Mar 31Resolved
Total Polychlorinated Biphenyls (PCB)
03
Mar 31Resolved
Dalapon
03
Mar 31Resolved
1,2-DIBROMO-3-CHLOROPROPANE
03
Mar 31Resolved
Carbofuran
03
Mar 31Resolved
HEXACHLOROBENZENE
03
Mar 31Resolved
Glyphosate
03
Mar 31Resolved
Benzo(a)pyrene
03
Mar 31Resolved
2,4-D
03
Mar 31Resolved
2,3,7,8-TCDD
03
Mar 31Resolved
Heptachlor epoxide
03
Mar 31Resolved
LASSO
03
Mar 31Resolved
2,4,5-TP
03
Mar 31Resolved
Diquat
03
Mar 31Resolved
Picloram
03
Mar 31Resolved
OXAMYL
03
Mar 31Resolved
Di(2-ethylhexyl) adipate
03
Mar 31Resolved
Atrazine
03
Mar 31Resolved
Endothall
03
Mar 31Resolved
Simazine
03
Mar 31Resolved
Di(2-ethylhexyl) phthalate
03
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
1,2-DIBROMO-3-CHLOROPROPANE
03
Mar 31Resolved
LASSO
03
Mar 31Resolved
Carbofuran
03
Mar 31Resolved
Di(2-ethylhexyl) adipate
03
Mar 31Resolved
OXAMYL
03
Mar 31Resolved
Benzo(a)pyrene
03
Mar 31Resolved
2,4-D
03
Mar 31Resolved
Dinoseb
03
Mar 31Resolved
Total Polychlorinated Biphenyls (PCB)
03
Mar 31Resolved
Hexachlorocyclopentadiene
03
Mar 31Resolved
Atrazine
03
Mar 31Resolved
Heptachlor
03
Mar 31Resolved
Simazine
03
Mar 31Resolved
2,3,7,8-TCDD
03
Mar 31Resolved
Methoxychlor
03
Mar 31Resolved
Picloram
03
Mar 31Resolved
Toxaphene
03
Mar 31Resolved
HEXACHLOROBENZENE
03
Mar 31Resolved
2,4,5-TP
03
Mar 31Resolved
ETHYLENE DIBROMIDE
03
Mar 31Resolved
Di(2-ethylhexyl) phthalate
03
Mar 31Resolved
Endothall
03
Mar 31Resolved
Chlordane
03
Mar 31Resolved
Heptachlor epoxide
03
Mar 31Resolved
Dalapon
03
Mar 31Resolved
Pentachlorophenol
03
Mar 31Resolved
Diquat
03
Mar 31Resolved
Endrin
03
Mar 31Resolved
BHC-GAMMA
03
Mar 31Resolved
Glyphosate
03
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Groundwater Rule
45
Feb 3Active
Revised Total Coliform Rule
3A
Jan 31Resolved
Revised Total Coliform Rule
3A
Jan 31Resolved
2024(161)
Revised Total Coliform Rule
5A
Dec 31Resolved
HEXACHLOROBENZENE
03
Dec 31Resolved
Benzo(a)pyrene
03
Dec 31Resolved
Total Polychlorinated Biphenyls (PCB)
03
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Pentachlorophenol
03
Dec 31Resolved
Endothall
03
Dec 31Resolved
Diquat
03
Dec 31Resolved
Dalapon
03
Dec 31Resolved
Methoxychlor
03
Dec 31Resolved
2,4,5-TP
03
Dec 31Resolved
Dinoseb
03
Dec 31Resolved
Endrin
03
Dec 31Resolved
OXAMYL
03
Dec 31Resolved
Hexachlorocyclopentadiene
03
Dec 31Resolved
Carbofuran
03
Dec 31Resolved
LASSO
03
Dec 31Resolved
2,4-D
03
Dec 31Resolved
BHC-GAMMA
03
Dec 31Resolved
1,2-DIBROMO-3-CHLOROPROPANE
03
Dec 31Resolved
ETHYLENE DIBROMIDE
03
Dec 31Resolved
Chlordane
03
Dec 31Resolved
Glyphosate
03
Dec 31Resolved
Di(2-ethylhexyl) adipate
03
Dec 31Resolved
Toxaphene
03
Dec 31Resolved
Picloram
03
Dec 31Resolved
2,3,7,8-TCDD
03
Dec 31Resolved
Simazine
03
Dec 31Resolved
Heptachlor
03
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Heptachlor epoxide
03
Dec 31Resolved
Atrazine
03
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Di(2-ethylhexyl) phthalate
03
Dec 31Resolved
Simazine
03
Dec 31Resolved
Dalapon
03
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
2,4,5-TP
03
Dec 31Resolved
Chlordane
03
Dec 31Resolved
Atrazine
03
Dec 31Resolved
2,3,7,8-TCDD
03
Dec 31Resolved
1,2-DIBROMO-3-CHLOROPROPANE
03
Dec 31Resolved
Glyphosate
03
Dec 31Resolved
HEXACHLOROBENZENE
03
Dec 31Resolved
LASSO
03
Dec 31Resolved
Pentachlorophenol
03
Dec 31Resolved
Hexachlorocyclopentadiene
03
Dec 31Resolved
ETHYLENE DIBROMIDE
03
Dec 31Resolved
Endrin
03
Dec 31Resolved
BHC-GAMMA
03
Dec 31Resolved
Methoxychlor
03
Dec 31Resolved
Toxaphene
03
Dec 31Resolved
Diquat
03
Dec 31Resolved
Endothall
03
Dec 31Resolved
Di(2-ethylhexyl) adipate
03
Dec 31Resolved
OXAMYL
03
Dec 31Resolved
Di(2-ethylhexyl) phthalate
03
Dec 31Resolved
Dinoseb
03
Dec 31Resolved
Carbofuran
03
Dec 31Resolved
2,4-D
03
Dec 31Resolved
Benzo(a)pyrene
03
Dec 31Resolved
Total Polychlorinated Biphenyls (PCB)
03
Dec 31Resolved
Heptachlor
03
Dec 31Resolved
Heptachlor epoxide
03
Dec 31Resolved
Picloram
03
Dec 31Resolved
Lead and Copper Rule
52
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
HEXACHLOROBENZENE
03
Dec 31Resolved
Hexachlorocyclopentadiene
03
Dec 31Resolved
2,3,7,8-TCDD
03
Dec 31Resolved
Di(2-ethylhexyl) phthalate
03
Dec 31Resolved
LASSO
03
Dec 31Resolved
BHC-GAMMA
03
Dec 31Resolved
Di(2-ethylhexyl) adipate
03
Dec 31Resolved
Benzo(a)pyrene
03
Dec 31Resolved
OXAMYL
03
Dec 31Resolved
Glyphosate
03
Dec 31Resolved
Dinoseb
03
Dec 31Resolved
Pentachlorophenol
03
Dec 31Resolved
Endrin
03
Dec 31Resolved
Chlordane
03
Dec 31Resolved
Heptachlor epoxide
03
Dec 31Resolved
Methoxychlor
03
Dec 31Resolved
1,2-DIBROMO-3-CHLOROPROPANE
03
Dec 31Resolved
2,4-D
03
Dec 31Resolved
Endothall
03
Dec 31Resolved
Diquat
03
Dec 31Resolved
ETHYLENE DIBROMIDE
03
Dec 31Resolved
Picloram
03
Dec 31Resolved
Simazine
03
Dec 31Resolved
Atrazine
03
Dec 31Resolved
Total Polychlorinated Biphenyls (PCB)
03
Dec 31Resolved
Toxaphene
03
Dec 31Resolved
Heptachlor
03
Dec 31Resolved
Dalapon
03
Dec 31Resolved
2,4,5-TP
03
Dec 31Resolved
Carbofuran
03
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
Revised Total Coliform Rule
3A
Oct 31Resolved
Revised Total Coliform Rule
3A
Oct 31Resolved
LEAD AND COPPER RULE REVISIONS
4G
Oct 16Active
LEAD AND COPPER RULE REVISIONS
2E
Oct 16Active
LEAD AND COPPER RULE REVISIONS
2E
Oct 16Active
LEAD AND COPPER RULE REVISIONS
4G
Oct 16Active
LEAD AND COPPER RULE REVISIONS
4G
Oct 16Active
LEAD AND COPPER RULE REVISIONS
2E
Oct 16Active
LEAD AND COPPER RULE REVISIONS
4G
Oct 16Active
LEAD AND COPPER RULE REVISIONS
2E
Oct 16Active
Consumer Confidence Rule
72
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Revised Total Coliform Rule
3A
Sep 30Resolved
Revised Total Coliform Rule
3A
Sep 30Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
E. COLI
34
Jul 1Resolved
Arsenic
02
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
4C
Jun 19Resolved
Arsenic
02
May 31Resolved
Arsenic
02
May 31Resolved
Arsenic
02
May 31Resolved
Arsenic
02
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
2D
May 27Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Arsenic
01
Mar 31Resolved
Arsenic
01
Mar 31Resolved
Arsenic
01
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Feb 29Resolved
Revised Total Coliform Rule
3A
Feb 29Resolved
Arsenic
02
Feb 29Resolved
Arsenic
02
Feb 29Resolved
Arsenic
02
Feb 29Resolved
Arsenic
02
Feb 29Resolved
Revised Total Coliform Rule
3A
Feb 29Resolved
Arsenic
02
Jan 31Resolved
Arsenic
02
Jan 31Resolved
Arsenic
02
Jan 31Resolved
Arsenic
02
Jan 31Resolved
Revised Total Coliform Rule
3A
Jan 31Resolved
2023(217)
Total Haloacetic Acids (HAA5)
27
Dec 31Resolved
TTHM
27
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
Nitrate
03
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
Nitrate
03
Dec 31Resolved
Nitrate
03
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
Nitrate
03
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Groundwater Rule
20
Dec 20Resolved
Revised Total Coliform Rule
3A
Nov 30Resolved
Revised Total Coliform Rule
3A
Nov 30Resolved
Revised Total Coliform Rule
3A
Nov 30Resolved
Arsenic
02
Nov 30Resolved
Arsenic
02
Nov 30Resolved
Arsenic
02
Nov 30Resolved
Arsenic
02
Nov 30Resolved
Arsenic
02
Nov 30Resolved
Arsenic
02
Nov 30Resolved
Arsenic
02
Nov 30Resolved
Arsenic
02
Nov 30Resolved
Arsenic
02
Nov 30Resolved
Revised Total Coliform Rule
3A
Nov 30Resolved
Revised Total Coliform Rule
3A
Oct 31Resolved
Revised Total Coliform Rule
3A
Oct 31Resolved
Revised Total Coliform Rule
3A
Oct 31Resolved
Arsenic
02
Oct 31Resolved
Arsenic
02
Oct 31Resolved
Arsenic
02
Oct 31Resolved
Arsenic
02
Oct 31Resolved
Arsenic
02
Oct 31Resolved
Arsenic
02
Oct 31Resolved
Arsenic
02
Oct 31Resolved
Arsenic
02
Oct 31Resolved
Revised Total Coliform Rule
3A
Oct 31Resolved
Groundwater Rule
45
Oct 27Active
Revised Total Coliform Rule
3A
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Revised Total Coliform Rule
3A
Sep 30Resolved
Revised Total Coliform Rule
3A
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Public Notice
75
Aug 31Resolved
Public Notice
75
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Arsenic
03
Aug 31Resolved
Arsenic
02
Aug 31Resolved
Arsenic
03
Aug 31Resolved
Arsenic
02
Aug 31Resolved
Arsenic
02
Aug 31Resolved
Arsenic
02
Aug 31Resolved
Arsenic
02
Aug 31Resolved
Arsenic
02
Aug 31Resolved
Arsenic
02
Aug 31Resolved
Arsenic
02
Aug 31Resolved
Arsenic
02
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Groundwater Rule
45
Aug 9Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Groundwater Rule
20
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Arsenic
02
Jul 31Resolved
Arsenic
03
Jul 31Resolved
Arsenic
02
Jul 31Resolved
Arsenic
02
Jul 31Resolved
Arsenic
02
Jul 31Resolved
Arsenic
02
Jul 31Resolved
Arsenic
02
Jul 31Resolved
Arsenic
02
Jul 31Resolved
Arsenic
03
Jul 31Resolved
Arsenic
02
Jul 31Resolved
Arsenic
02
Jul 31Resolved
Arsenic
03
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
4C
Jun 10Resolved
Revised Total Coliform Rule
4C
Jun 10Resolved
Revised Total Coliform Rule
4C
Jun 10Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Arsenic
02
May 31Resolved
Arsenic
02
May 31Resolved
Arsenic
02
May 31Resolved
Arsenic
02
May 31Resolved
Arsenic
02
May 31Resolved
Arsenic
02
May 31Resolved
Arsenic
02
May 31Resolved
Arsenic
02
May 31Resolved
Arsenic
02
May 31Resolved
Arsenic
02
May 31Resolved
Arsenic
02
May 31Resolved
Arsenic
02
May 31Resolved
Arsenic
02
May 31Resolved
Arsenic
02
May 31Resolved
Arsenic
02
May 31Resolved
Arsenic
02
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Arsenic
02
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
03
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Revised Total Coliform Rule
3A
Jan 31Resolved
Revised Total Coliform Rule
3A
Jan 31Resolved
Revised Total Coliform Rule
3A
Jan 31Resolved
Revised Total Coliform Rule
3A
Jan 31Resolved
Revised Total Coliform Rule
3A
Jan 31Resolved
Revised Total Coliform Rule
3A
Jan 31Resolved
2022(161)
Nitrate
03
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Lead and Copper Rule
52
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
Nitrate
03
Dec 31Resolved
Nitrate
03
Dec 31Resolved
Lead and Copper Rule
52
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
Lead and Copper Rule
52
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
Nitrate
03
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Nitrate
03
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
Revised Total Coliform Rule
3A
Nov 30Resolved
Revised Total Coliform Rule
3A
Nov 30Resolved
Revised Total Coliform Rule
3A
Nov 30Resolved
Revised Total Coliform Rule
3A
Nov 30Resolved
Revised Total Coliform Rule
3A
Oct 31Resolved
Revised Total Coliform Rule
3B
Oct 31Resolved
Revised Total Coliform Rule
3B
Oct 31Resolved
Revised Total Coliform Rule
3A
Oct 31Resolved
Revised Total Coliform Rule
3A
Oct 31Resolved
Consumer Confidence Rule
72
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Consumer Confidence Rule
72
Sep 30Resolved
Revised Total Coliform Rule
3A
Sep 30Resolved
Consumer Confidence Rule
72
Sep 30Resolved
Consumer Confidence Rule
72
Sep 30Resolved
Revised Total Coliform Rule
3A
Sep 30Resolved
Revised Total Coliform Rule
3A
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Revised Total Coliform Rule
3A
Sep 30Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Chlorine
27
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
4C
Jun 19Resolved
Revised Total Coliform Rule
2D
Jun 9Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Revised Total Coliform Rule
3A
Jan 31Resolved
Revised Total Coliform Rule
3A
Jan 31Resolved
Revised Total Coliform Rule
3A
Jan 31Resolved
Revised Total Coliform Rule
3A
Jan 31Resolved
2021(146)
Revised Total Coliform Rule
3A
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Arsenic
02
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
Revised Total Coliform Rule
3A
Dec 31Resolved
Revised Total Coliform Rule
3A
Nov 30Resolved
Revised Total Coliform Rule
3A
Nov 30Resolved
Revised Total Coliform Rule
3A
Nov 30Resolved
Revised Total Coliform Rule
3A
Oct 31Resolved
Revised Total Coliform Rule
3A
Oct 31Resolved
Arsenic
02
Sep 30Resolved
Arsenic
03
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Arsenic
02
Sep 30Resolved
Consumer Confidence Rule
72
Sep 30Resolved
Consumer Confidence Rule
72
Sep 30Resolved
Consumer Confidence Rule
72
Sep 30Resolved
Consumer Confidence Rule
72
Sep 30Resolved
Consumer Confidence Rule
72
Sep 30Resolved
Consumer Confidence Rule
72
Sep 30Resolved
Revised Total Coliform Rule
3A
Sep 30Resolved
Revised Total Coliform Rule
3A
Sep 30Resolved
Consumer Confidence Rule
72
Sep 30Resolved
Consumer Confidence Rule
72
Sep 30Resolved
Revised Total Coliform Rule
3A
Sep 30Resolved
Revised Total Coliform Rule
3A
Sep 30Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3B
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Aug 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Revised Total Coliform Rule
3A
Jul 31Resolved
Public Notice
75
Jul 11Resolved
Public Notice
75
Jul 11Resolved
Public Notice
75
Jul 11Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
03
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Arsenic
02
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Consumer Confidence Rule
71
Jun 30Resolved
Revised Total Coliform Rule
3A
Jun 30Resolved
Revised Total Coliform Rule
2D
Jun 9Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
May 31Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Revised Total Coliform Rule
3A
Apr 30Resolved
Public Notice
75
Apr 17Resolved
Public Notice
75
Apr 17Resolved
Public Notice
75
Apr 17Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Arsenic
02
Mar 31Resolved
Revised Total Coliform Rule
3A
Mar 31Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Revised Total Coliform Rule
3A
Feb 28Resolved
Public Notice
75
Feb 18Resolved
Public Notice
75
Feb 18Resolved
Public Notice
75
Feb 18Resolved
Public Notice
75
Feb 18Resolved
How Does This Compare?
SOLDOTNA (99669) has 771 recorded violations, including 300 health-based. 12 remain unresolved. Consider testing your tap water independently for added peace of mind.
Recommended Water Filters
Based on the contaminants detected in your area, these filter types may help improve your water quality.
Reverse Osmosis System
Highly effective at removing heavy metals, dissolved solids, and a wide range of contaminants. Recommended for homes with lead or arsenic concerns.
Targets:Lead, Copper, Arsenic, Mercury, Cadmium
Look for:NSF/ANSI 58 certified
Activated Carbon Filter
Excellent for removing chlorine, chloramine, and disinfection byproducts like THMs and HAAs. Available as pitcher filters, countertop, or under-sink units.
Targets:THMs, HAAs, Chlorine, Chloramine, Taste & Odor
Look for:NSF/ANSI 42 & 53 certified
UV Water Purifier
Uses ultraviolet light to neutralize bacteria, viruses, and parasites without chemicals. Ideal for homes with microbial contamination concerns.
Targets:E. coli, Coliform, Giardia, Cryptosporidium
Look for:NSF/ANSI 55 (Class A) certified
Always look for filters certified by NSF International for the specific contaminants you want to remove.